Demand for PGT-A (Third-Gen IVF) Surges 22% in China Amid Demographic Changes

Written By camellia chen

【Abstract】: (Data Trend) Preliminary Q4 2025 data from the China Association of Reproductive Medicine shows a 22% year-on-year increase in Preimplantation Genetic Testing (PGT) cycles. This growth outpaces standard IVF (8%), driven by the rising average maternal age (now 34.5 years) and increased awareness of genetic disease prevention.

Business Insight: The market is moving up the value chain. "Third-Gen" IVF offers higher margins and better clinical outcomes for older patients. Clinics that have not yet upgraded their genetic counseling and biopsy capabilities risk being left behind in the low-margin "standard IVF" commoditized market.

  1. 【Keywords】: #PGTMarket #ThirdGenIVF #ChinaGrowth

  2. 【Source】: CSRM Data / Yicai Global (Feb 2026)

camellia chen
Previous

GBA Integration: Hong Kong Northern Metropolis Designated as Cross-Border Reproductive Genetics Hub
Next

Vitrolife Strengthens China Footprint with Acquisition of Local Consumables Manufacturer